Boiron faults homeopathy attack in Lancet

The US unit ofFrance's Boiron group has disputed an editorial comment published in The Lancet's November 17 issue claiming that its author has misinterpreted results of clinical trials on homeopathic medicines.

The UK-based medical journal features an editorial by Ben Goldacre on the Benefits and Risks of Homeopathy. In his commentary, Mr Goldacre suggests that the results from five large meta-analyses indicate that homeopathy produces no statistically-significant benefit over placebo. However, a thorough review of the studies' research evidence indicates positive principle conclusions in favor of homeopathy over placebo. Boiron said that the Kleijnen et al study states that "the evidence of clinical trials is positive but not sufficient to draw any definite conclusions."